Literature DB >> 26012360

Aging, Practice Effects, and Genetic Risk in the Wisconsin Registry for Alzheimer's Prevention.

Erin M Jonaitis1, Rebecca L Koscik, Asenath La Rue, Sterling C Johnson, Bruce P Hermann, Mark A Sager.   

Abstract

BACKGROUND: In the last five years, a consensus has developed that Alzheimer's disease (AD) may begin years before overt cognitive impairment. Accordingly, the focus has shifted to identifying preclinical disease in order to match treatments to those most likely to benefit. Subtle cognitive changes, including reduced benefit from practice, may be one such preclinical sign. In this study, we explore cognitive aging trajectories within a large cohort of clinically intact late middle-aged adults.
METHOD: Longitudinal cognitive data were analyzed from 594 participants in the Wisconsin Registry for Alzheimer's Prevention. Mixed models were used to examine trajectories, adjusting for prior exposure, and the moderation thereof by markers of dementia risk, APOE-ε4 status, and family history of AD.
RESULTS: Practice effects were observed for Verbal Learning & Memory, Working Memory, Speed & Flexibility, and Visual Learning. However, for Working Memory and Speed & Flexibility, these effects were attenuated for FH + subjects.
CONCLUSION: Reduced practice effects have previously been observed in clinical groups. These results in middle-aged adults suggest that they may also indicate preclinical changes on the path to AD.

Entities:  

Keywords:  Cognitive aging; Practice effects; Preclinical Alzheimer’s disease.

Mesh:

Substances:

Year:  2015        PMID: 26012360      PMCID: PMC4501866          DOI: 10.1080/13854046.2015.1047407

Source DB:  PubMed          Journal:  Clin Neuropsychol        ISSN: 1385-4046            Impact factor:   3.535


  30 in total

1.  A comparison of factor scores under conditions of factor obliquity.

Authors:  J W Grice
Journal:  Psychol Methods       Date:  2001-03

2.  Mild cognitive impairment can be detected by multiple assessments in a single day.

Authors:  D Darby; P Maruff; A Collie; M McStephen
Journal:  Neurology       Date:  2002-10-08       Impact factor: 9.910

3.  Category fluency in mild cognitive impairment: reduced effect of practice in test-retest conditions.

Authors:  D B Cooper; L H Lacritz; M F Weiner; R N Rosenberg; C M Cullum
Journal:  Alzheimer Dis Assoc Disord       Date:  2004 Jul-Sep       Impact factor: 2.703

4.  Effects of practice on category fluency in Alzheimer's disease.

Authors:  D B Cooper; M Epker; L Lacritz; M Weine; R N Rosenberg; L Honig; C M Cullum
Journal:  Clin Neuropsychol       Date:  2001-02       Impact factor: 3.535

5.  Practice effects and longitudinal cognitive change in normal aging vs. incident mild cognitive impairment and dementia in the Mayo Clinic Study of Aging.

Authors:  Mary M Machulda; V Shane Pankratz; Teresa J Christianson; Robert J Ivnik; Michelle M Mielke; Rosebud O Roberts; David S Knopman; Bradley F Boeve; Ronald C Petersen
Journal:  Clin Neuropsychol       Date:  2013-09-17       Impact factor: 3.535

6.  Emergence of mild cognitive impairment in late middle-aged adults in the wisconsin registry for Alzheimer's prevention.

Authors:  Rebecca L Koscik; Asenath La Rue; Erin M Jonaitis; Ozioma C Okonkwo; Sterling C Johnson; Barbara B Bendlin; Bruce P Hermann; Mark A Sager
Journal:  Dement Geriatr Cogn Disord       Date:  2014-02-20       Impact factor: 2.959

7.  Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease.

Authors:  G McKhann; D Drachman; M Folstein; R Katzman; D Price; E M Stadlan
Journal:  Neurology       Date:  1984-07       Impact factor: 9.910

8.  A validation study of the Dementia Questionnaire.

Authors:  C Kawas; J Segal; W F Stewart; M Corrada; L J Thal
Journal:  Arch Neurol       Date:  1994-09

9.  Alzheimer disease in the United States (2010-2050) estimated using the 2010 census.

Authors:  Liesi E Hebert; Jennifer Weuve; Paul A Scherr; Denis A Evans
Journal:  Neurology       Date:  2013-02-06       Impact factor: 9.910

10.  Apolipoprotein E: high-avidity binding to beta-amyloid and increased frequency of type 4 allele in late-onset familial Alzheimer disease.

Authors:  W J Strittmatter; A M Saunders; D Schmechel; M Pericak-Vance; J Enghild; G S Salvesen; A D Roses
Journal:  Proc Natl Acad Sci U S A       Date:  1993-03-01       Impact factor: 11.205

View more
  8 in total

1.  [Formula: see text]Practice effects and longitudinal cognitive change in clinically normal older adults differ by Alzheimer imaging biomarker status.

Authors:  Mary M Machulda; Clint E Hagen; Heather J Wiste; Michelle M Mielke; David S Knopman; Rosebud O Roberts; Prashanthi Vemuri; Val J Lowe; Clifford R Jack; Ronald C Petersen
Journal:  Clin Neuropsychol       Date:  2016-10-11       Impact factor: 3.535

Review 2.  Cognitive Functioning of Unaffected First-degree Relatives of Individuals With Late-onset Alzheimer's Disease: A Systematic Literature Review and Meta-analysis.

Authors:  Ari Alex Ramos; Noelia Galiano-Castillo; Liana Machado
Journal:  Neuropsychol Rev       Date:  2022-09-03       Impact factor: 6.940

3.  Cardiorespiratory fitness and cognition in persons at risk for Alzheimer's disease.

Authors:  Clayton J Vesperman; Rui Wang; Stephanie A Schultz; Lena L Law; Ryan J Dougherty; Yue Ma; Jennifer M Oh; Dorothy F Edwards; Catherine L Gallagher; Nathaniel A Chin; Sanjay Asthana; Bruce P Hermann; Mark A Sager; Sterling C Johnson; Dane B Cook; Ozioma C Okonkwo
Journal:  Alzheimers Dement (Amst)       Date:  2022-07-08

4.  Age-accelerated cognitive decline in asymptomatic adults with CSF β-amyloid.

Authors:  Lindsay R Clark; Sara E Berman; Derek Norton; Rebecca L Koscik; Erin Jonaitis; Kaj Blennow; Barbara B Bendlin; Sanjay Asthana; Sterling C Johnson; Henrik Zetterberg; Cynthia M Carlsson
Journal:  Neurology       Date:  2018-03-09       Impact factor: 9.910

Review 5.  The Wisconsin Registry for Alzheimer's Prevention: A review of findings and current directions.

Authors:  Sterling C Johnson; Rebecca L Koscik; Erin M Jonaitis; Lindsay R Clark; Kimberly D Mueller; Sara E Berman; Barbara B Bendlin; Corinne D Engelman; Ozioma C Okonkwo; Kirk J Hogan; Sanjay Asthana; Cynthia M Carlsson; Bruce P Hermann; Mark A Sager
Journal:  Alzheimers Dement (Amst)       Date:  2017-12-08

6.  The effect of rare variants in TREM2 and PLD3 on longitudinal cognitive function in the Wisconsin Registry for Alzheimer's Prevention.

Authors:  Corinne D Engelman; Burcu F Darst; Murat Bilgel; Eva Vasiljevic; Rebecca L Koscik; Bruno M Jedynak; Sterling C Johnson
Journal:  Neurobiol Aging       Date:  2017-12-29       Impact factor: 4.673

7.  Modeling practice effects in healthy middle-aged participants of the Alzheimer and Families parent cohort.

Authors:  Gonzalo Sánchez-Benavides; Juan D Gispert; Karine Fauria; José Luis Molinuevo; Nina Gramunt
Journal:  Alzheimers Dement (Amst)       Date:  2016-08-30

8.  Lower practice effects as a marker of cognitive performance and dementia risk: A literature review.

Authors:  Roos J Jutten; Evan Grandoit; Nancy S Foldi; Sietske A M Sikkes; Richard N Jones; Seo-Eun Choi; Melissa L Lamar; Diana K N Louden; Joanne Rich; Douglas Tommet; Paul K Crane; Laura A Rabin
Journal:  Alzheimers Dement (Amst)       Date:  2020-07-09
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.